#National Institute of Allergy and Infectious Diseases

Periodic infusions of such antibodies may eventually become a new way of treating the virus.

The iconic AIDS activist sounded off in a STAT interview—and shared how he’s spending his declining years.

Promising news on the prevention front

It’s the NIH’s first large-scale clinical trial on the subject. Plus: Meet organ transplant advocate Mo Murray [VIDEO].

With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

A statement from the National Institutes of Health on World AIDS Day 2017.

The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.

Three antibodies combined into one protected monkeys against a simian version of HIV, opening the door for human trials.

HIV scientists and advocates are waging a powerful war against the global epidemic.

A 9-year-old South African child infected with HIV at birth has been in an apparent state of extended viral remission.

A new HIV vaccine regimen was well tolerated and elicited a good immune response among participants of a study who did not have the virus.

Researchers found a way to block a protein linked with blood clotting and inflammatory processes using a drug derived from tick saliva.

Gazing into the crystal ball at the epidemic’s future reveals many exciting advancements. Lower infection rates is just the beginning.

Plus: This timeline of HIV vaccine research includes today’s HVTN 702 trial—the first new major trial in seven years.